within Pharmacolibrary.Drugs.ATC.G;

model G04BE02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.16999999999999998,
    adminDuration  = 600,
    adminMass      = 0.15,
    adminCount     = 1,
    Vd             = 0.0025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Papaverine is an opium alkaloid antispasmodic drug used primarily to treat visceral spasm, vasospasm (including cerebral vasospasm after subarachnoid hemorrhage), and sometimes erectile dysfunction. While it was historically used for gastrointestinal spasms, its clinical use has declined due to the availability of safer alternatives, but it is still approved for some indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics of papaverine in healthy adult male volunteers following intravenous administration.</p><h4>References</h4><ol><li><p>Kraus, C, et al., &amp; Ritschel, WA (1991). Pharmacokinetics and bioavailability of papaverine HCl following intravenous, peroral, rectal, vaginal, topical and buccal administration in beagle dogs. <i>Biopharmaceutics &amp; drug disposition</i> 12(7) 537–546. DOI:<a href=&quot;https://doi.org/10.1002/bdd.2510120707&quot;>10.1002/bdd.2510120707</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1932615/&quot;>https://pubmed.ncbi.nlm.nih.gov/1932615</a></p></li><li><p>Ritschel, WA, &amp; Hammer, GV (1977). Pharmacokinetics of papaverine in man. <i>International journal of clinical pharmacology and biopharmacy</i> 15(5) 227–228. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/873666/&quot;>https://pubmed.ncbi.nlm.nih.gov/873666</a></p></li><li><p>Shaaya, AN, et al., &amp; Ritschel, WA (1992). Pharmacokinetics and bioavailability of papaverine HCl after intravenous, intracorporeal and penis topical administration in beagle dogs. <i>Methods and findings in experimental and clinical pharmacology</i> 14(5) 373–378. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1513193/&quot;>https://pubmed.ncbi.nlm.nih.gov/1513193</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G04BE02;
